Last reviewed · How we verify
Tramadol HCl, 50 mg
Tramadol HCl, 50 mg is a Small molecule drug developed by Janssen Scientific Affairs, LLC. It is currently in Phase 1 development.
At a glance
| Generic name | Tramadol HCl, 50 mg |
|---|---|
| Sponsor | Janssen Scientific Affairs, LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Nausea
- Vomiting
- Dizziness
- Procedural pain
- Headache
- Somnolence
- Asthenia
- Vertigo
- Nasopharyngitis
- Post procedural inflammation
- Hypoaesthesia
- Tinnitus
Key clinical trials
- Opioid-Free Pain Protocol After Shoulder Arthroplasty (PHASE4)
- Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma (PHASE4)
- Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain (NA)
- Investigation of the Effect of Proximal and Distal Adductor Canal Block in Knee Replacement Surgery (NA)
- RIB for Perioperative Analgesia in CIED Patients (NA)
- Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back Pain (PHASE4)
- Analgesic Efficacy of Ropivacaine Alone or in Combination With Adjuvants on Post-operative Analgesia Following Video-Assisted Thoracoscopic Surgery. (PHASE4)
- Use of Tramadol Intraligamentary Injections (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tramadol HCl, 50 mg CI brief — competitive landscape report
- Tramadol HCl, 50 mg updates RSS · CI watch RSS
- Janssen Scientific Affairs, LLC portfolio CI
Frequently asked questions about Tramadol HCl, 50 mg
What is Tramadol HCl, 50 mg?
Tramadol HCl, 50 mg is a Small molecule drug developed by Janssen Scientific Affairs, LLC.
Who makes Tramadol HCl, 50 mg?
Tramadol HCl, 50 mg is developed by Janssen Scientific Affairs, LLC (see full Janssen Scientific Affairs, LLC pipeline at /company/janssen-scientific-affairs-llc).
What development phase is Tramadol HCl, 50 mg in?
Tramadol HCl, 50 mg is in Phase 1.
What are the side effects of Tramadol HCl, 50 mg?
Common side effects of Tramadol HCl, 50 mg include Nausea, Vomiting, Dizziness, Procedural pain, Headache, Somnolence.
Related
- Manufacturer: Janssen Scientific Affairs, LLC — full pipeline
- Compare: Tramadol HCl, 50 mg vs similar drugs
- Pricing: Tramadol HCl, 50 mg cost, discount & access